Index Venture Life Associates VI Ltd Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001865139

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedBuy & Hold how tags are computed

Q1 2026 · 1 positions · Total reported value $395.68M · Top-10 concentration 100.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 0.0% · 0 new · 0 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q1 2026 13F filing, Index Venture Life Associates VI Ltd disclosed 1 equity positions with a combined reported value of $395.68M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Buy & Hold.

The largest disclosed positions as of Q1 2026 were CNTA ($395.68M). By sector, the heaviest allocations are Other 100.0%.

Versus the prior quarter, Index Venture Life Associates VI Ltd opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest Index Venture Life Associates VI Ltd buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-06-24 Sell Centessa Pharmaceuticals plc 149,421 — SEC filing
2026-06-24 Sell Centessa Pharmaceuticals plc 9,812,368 — SEC filing

All insider transactions →

Fund Profile

Index Venture Life Associates VI Ltd is an SEC-registered 13F filer. As of Q1 2026 it reported 1 US equity positions with a combined value of $395.68M. HoldingsHub carries 6 quarters of its filings (Q4 2024–Q1 2026).

Portfolio Structure

  • 1 positions · $395.68M reported value (Q1 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: CNTA (CENTESSA PHARMACEUTICALS PLC) at 100.0%
  • Average position size: $395.68M

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Other 100.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 9.96M $395.68M 100.00%
100.00%
Hold

FAQ

What did Index Venture Life Associates VI Ltd buy in 2026-Q1?

In its 2026-Q1 13F filing, Index Venture Life Associates VI Ltd reported 1 equity positions worth $395.68M in aggregate; its largest disclosed positions were CNTA ($395.68M).

How large is Index Venture Life Associates VI Ltd's portfolio?

Index Venture Life Associates VI Ltd reported $395.68M of long equity holdings across 1 positions as of 2026-Q1. Top-10 holdings account for 100.0% of reported value.

What is Index Venture Life Associates VI Ltd's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/index-venture-life-associates-vi/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →